|
FY2025
12 months to Dec 31, 2025
|
FY2024
12 months to Dec 31, 2024
|
FY2023
12 months to Dec 31, 2023
|
FY2022
12 months to Dec 31, 2022
|
FY2021
12 months to Dec 31, 2021
|
|
|---|---|---|---|---|---|
| Net sales | |||||
| Cost of sales | |||||
| Gross profit | |||||
| Selling, general and administrative expenses | |||||
| Research and development expenses | |||||
| Restructuring, impairment and other asset charges, net | |||||
| Restructuring, impairment and other asset (gains) charges, net | |||||
| Income from operations | |||||
| Other expenses, net: | |||||
| Interest expense | |||||
| Interest income | |||||
| Other income (expenses), net | |||||
| Income before income taxes | |||||
| Income tax provision | |||||
| Net income | |||||
| Net loss (income) attributable to noncontrolling interest | |||||
| Net income attributable to controlling interest | |||||
| Per share data: | |||||
| Earnings per common share - Basic (in dollars per share) | |||||
| Earnings per common share - Diluted (in dollars per share) | |||||
| Weighted average shares outstanding - Basic (in shares) | |||||
| Weighted average shares outstanding - Diluted (in shares) |
Loading...